INTRODUCTION
============

Group A streptococcus (GAS), or *Streptococcus pyogenes*, is a facultative, Gram-positive β-hemolytic cocci which causes wide range of diseases in humans, from mild to life-threatening ones, such as pharyngitis, scarlet fever, tonsillitis, cellulitis, impetigo, erysipelas, vulvovaginitis, pneumonia, endocarditis, meningitis, sepsis, necrotizing fasciitis and myonecrosis ([@B1]). *S. pyogenes* is one of the major causes of acute respiratory tract infections. This pathogen is known to cause autoimmune post-streptococcal sequelae, such as acute rheumatic fever and acute glomerulonephritis. Worldwide, more than 18 million people are suffering from serious GAS disease. This burden is a major cause of illness and death among children and young adults, including pregnant women, in resource poor countries ([@B2]).

Antibiotic resistance pattern of this organism has been changing in recent years and it is mainly because of inappropriate usage of broad spectrum antibiotics ([@B3]). The frequency of resistance of GAS to various antibiotics is increasing globally ([@B4]). Currently, penicillin is the drug of choice for GAS pharyngitis and penicillin resistance for GAS has not been reported yet ([@B3], [@B5]). However, the prevalence of antibiotic resistance among GAS is increasing day by day.

From time to time surveillance is needed to monitor the changes in antibiotic susceptibility profile of GAS in order to guide clinicians to choose appropriate antibiotics. There is not sufficient data in literature pertaining to antibiotic resistance of GAS in Indian setup till date. Therefore, this study was conducted to evaluate the prevalence and degree of antibiotic resistance among GAS.

MATERIALS AND METHODS
=====================

A retrospective study was conducted over a period of two years from January 2016 to December 2017 in the Department of Microbiology of a tertiary care teaching hospital in southern India. All throat swabs and ear swabs from the patients having signs and symptoms of upper respiratory tract infections were included in the study. Aseptic collection of swabs was done using sterile cotton swabs and transported to the Microbiology laboratory within 2 hours. Upon arrival, sample was inoculated on 5% sheep blood agar followed by Gram staining. All cultures were incubated in 5% CO~2~ at 37°C for 24 hours. The culture plates were observed for β-hemolytic colonies. Identification of *S. pyogenes* was made based on morphology in Gram stain and beta hemolytic growth on sheep blood agar medium and bacitracin susceptibility. Identification was further also confirmed with Matrix Assisted Laser Desorption/Ionization-Time of Flight (MALDI-TOF) Mass Spectrometry (VITEK MS, bioMerieux).

Bacitracin sensitivity test was performed using 0.04 units Bacitracin discs (Himedia Laboratories, Mumbai, India) as per standard protocol. After incubation of 18--24 hours, a zone of inhibition ≥ 15 mm was considered as sensitive. Antibiotic susceptibility test was done with automated microbial identification systems, VITEK 2 (bioMerieux) and minimum inhibitory concentrations (MIC) were noted. Isolates which were resistant to two or more groups of antibiotics were considered as multi drug resistant ([@B6]). Data was analysed using SPSS 16 version.

RESULTS
=======

Over a span of 2 years, 2123 respiratory samples were collected, out of which 1454 were throat swabs and 669 were ear swabs. Among these, 50 specimens comprising of 42 throat swabs (84%) and 8 (16%) ear swabs were positive for *S. pyogenes.* Male predominance was seen in 27 isolates (54%). Demographic details of the patients isolates are shown in [Table 1](#T1){ref-type="table"}. Among 50, 30 were MDR *S. pyogenes.* Isolates resistant to two or more groups of antibiotics were considered to be MDR ([@B7]).

###### 

Demographic details of cases infected by *Streptococcus pyogenes*

  **Age of the patients**   **Gender of the patients**   **Throat swab (n=42)**   **Ear swab (n=8)**       
  ------------------------- ---------------------------- ------------------------ -------------------- --- ---
  ≤18 years                 Male (n=17)                  10                       5                    2   0
  Female (n=8)              3                            2                        3                    0   
  \>18 years                Male (n=10)                  7                        1                    1   1
  Female (n=15)             4                            10                       0                    1   

[Table 2](#T2){ref-type="table"} shows various other isolates obtained from throat and ear swabs. [Fig. 1](#F1){ref-type="fig"} shows the seasonal variation of *S. pyogenes*. The results of antibiotic susceptibility test performed by VITEK 2 are shown in [Table 3](#T3){ref-type="table"}. In the present study, 92.1% isolates were sensitive to penicillin and 8% were non-sensitive. Out of 50 isolates, 3 isolates were not susceptible to penicillin and their MIC range was 0.5 to 8 μg/ml. The three penicillin non-susceptible isolates are shown in [Table 4](#T4){ref-type="table"}.

###### 

Various organisms isolated from throat swabs and ear swabs

  **Name of the isolate**         **Throat swab (n=124, out of 1454)**   **Ear Swab (n=387, out of 669)**   **Number of isolates (n=511, out of 2123)**   **Percentage**
  ------------------------------- -------------------------------------- ---------------------------------- --------------------------------------------- ----------------
  Methicillin sensitive           51                                     104                                155                                           30.33
  *Staphylococcus aureus*                                                                                                                                 
  Methicillin resistant           21                                     38                                 59                                            11.54
  *Staphylococcus aureus*                                                                                                                                 
  *Streptococcus pneumoniae*      5                                      1                                  6                                             1.17
  *Pseudomonas aeruginosa*        7                                      141                                148                                           28.9
  *Streptococcus agalactiae*      18                                     1                                  19                                            3.71
  *Haemophilus influenzae*        5                                      5                                  10                                            1.95
  *Acinetobacter*                 3                                      17                                 20                                            3.91
  *Escherichia coli*              6                                      13                                 19                                            3.71
  *Klebsiella pneumoniae*         8                                      23                                 31                                            6.06
  *Proteus mirabilis*             0                                      5                                  5                                             0.97
  *Citrobacter koseri*            0                                      1                                  1                                             0.19
  *Citrobacter freundii*          0                                      1                                  1                                             0.19
  *Burkholderia cepacia*          0                                      2                                  2                                             0.39
  *Aspergillus fumigatus*         0                                      5                                  5                                             0.97
  *Aspergillus flavus*            0                                      3                                  3                                             0.58
  *Aspergillus niger*             0                                      1                                  1                                             0.19
  *Bordetella trematum*           0                                      1                                  1                                             0.19
  *Candida species*               0                                      1                                  1                                             0.19
  *Enterococcus faecalis*         0                                      3                                  3                                             0.58
  *Curvularia cryoscens*          0                                      1                                  1                                             0.19
  *Serratia marcescens*           0                                      5                                  5                                             0.97
  *Providencia stuartii*          0                                      5                                  5                                             0.97
  *Providencia rettgeri*          0                                      1                                  1                                             0.19
  *Achromobacter denitrificans*   0                                      2                                  2                                             0.39
  *Enterobacter cloacae*          0                                      5                                  5                                             0.97
  *Enterobacter aerogenes*        0                                      1                                  1                                             0.19
  *Morganella morganii*           0                                      1                                  1                                             0.19
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###### 

Susceptibility rates of *Streptococcus pyogenes* to different antibiotics

  **Antibiotics**           **Mean Values ± SD (mm)**   **Cut off values Sensitive (CLSI)~(μg/mL)~**   **Sensitive n = (%)**   **Intermediate n = (%)**   **Resistant n = (%)**
  ------------------------- --------------------------- ---------------------------------------------- ----------------------- -------------------------- -----------------------
  Ampicillin (n=50)         0.76 ± 2.61                 ≤0.25                                          46 (92)                 0                          4 (8)
  Cefotaxime (n=48)         0.40 ± 1.30                 ≤0.5                                           46 (95.8)               0                          2 (4.2)
  Erythromycin (n=47)       4.30 ± 3.21                 ≤0.25                                          8 (17)                  0                          39 (83)
  Tetracycline (n=49)       7.58 ± 7.89                 ≤ 2                                            24 (49)                 0                          25 (51)
  Levofloxacin (n=45)       2.03 ± 4.22                 ≤ 2                                            39 (86.7)               2 (4.4)                    4 (8.9)
  Clindamycin (n=50)        1.40 ± 0.49                 ≤0.25                                          30 (60)                 0                          20 (40)
  Benzylpenicillin (n=38)   0.33 ± 1.31                 ≤0.12                                          35 (92.1)               3 (7.9)                    0
  Ceftriaxone (n=38)        0.35 ± 1.28                 ≤0.5                                           36 (94.7)               0                          2 (5.3)

###### 

Penicillin non-susceptible strains of *Streptococcus pyogenes*

  **Strain Characteristics**       **Isolate 1**   **Isolate 2**   **Isolate 3**
  -------------------------------- --------------- --------------- ---------------
  Age of patients                  12 years        19 years        4 years
  Susceptibility to Erythromycin   Sensitive       Resistant       Resistant
  Susceptibility to Clindamycin    Resistant       Sensitive       Resistant
  Susceptibility to Vancomycin     Resistant       Resistant       Sensitive
  Susceptibility to Tetracycline   Resistant       Sensitive       Resistant

The prevalence of cefotaxime, erythromycin, tetracycline, levofloxacin, clindamycin and ceftriaxone resistance were 4.2%, 83%, 51%, 8.9%, 40% and 5.3% respectively.

DISCUSSION
==========

In the present study, *Streptococcus pyogenes* showed seasonal variation. There was an increase in the number of cases during February--March and August--September in the last two years. This August--September is the monsoon season in south Karnataka which can be related to increase in number of cases of pharyngitis. During the months of February--March, there is change of weather from winter to summer, which leads to increase in number of pharyngitis cases. However, there is no documented evidence of association of pharyngitis cases with seasonal variation.

There are many therapeutic options for *Streptococcus* pharyngitis but benzathine penicillin is the drug of choice. However, clinical failures are being reported following penicillin therapy. Hence, monitoring MIC for penicillin is advisable in referral centers. In patients who are allergic to penicillin, other options such as macrolides, oral β-lactams, clindamycin or oral cephalosporins are used ([@B7]). Thus, the awareness of local antimicrobial susceptibility patterns among physicians becomes significant to select appropriate alternative treatment options.

Surprisingly, in present study 8% strains (n=3) were non-susceptible to penicillin. Their MIC was ≥0.12 μg/ml (CLSI guidelines). In this study, we found an increase in penicillin MIC ranging from 0.12 to 8 μg/ml. European Society of Clinical Microbiology and Infectious Disease reported in 2013 that MIC of penicillin was \<0.25 μg/ml against Group A. Comparable results to our study with respect to the penicillin MIC were revealed from different countries: India -- 0.16 to 0.75 ([@B8]), Mexico - 0.003 to 0.75 ([@B9]), Japan -- 0.12 to 2 μg/ml ([@B10]). This highlights the significance of reconsidering patterns of penicillin susceptibility.

Resistance of *Streptococcus pyogenes* to macrolides is mainly due to Erm (B) or Mef (A). Erm (B) is the main indicator of high level macrolide resistance whereas Erm (A) indicates low level resistance to macrolides only. Resistance of *Streptococcus pyogenes* to macrolides ranges from 2% to 19% depending on different localities. According to Glauber et al. ([@B11]), presence of this resistance is linked to iM-LSB phenotype that is responsible for inducible clindamycin resistance. According to Muhtarova AA et al., resistance of ~i~MLS~B~ phenotype was 22.55% ([@B12]). In the present study, 31.6% strains were positive for ~i~MLS~B~, whereas 68.4% strains were negative. Overall clindamycin resistance was observed in 40% strains. High observed resistance can be explained as there is extensive use of macrolides for treatment of GAS resulting in increased resistance towards them. Other reason can be their easy availability over the counter. In our study, we found erythromycin MIC of 1 to 8 mg/L and resistance percentage is 83%, which is quite high when compared with other studies. Study done by Khosravi et al. ([@B13]) showed erythromycin resistance of 1%, whereas study done by Shirin et al. ([@B14]), Lu B et al. ([@B15]) and Magnussen MD et al. ([@B16]) showed erythromycin resistance of 33.9%, 94.2% and 6% respectively. Although some studies from 2002 to 2012 with no GAS resistance to ceftriaxone exist ([@B17], [@B18]), but 2 isolates (5.3%) of the GAS strains in the current study were observed to show higher MIC to this antibiotic, which may be due to over-usage of ceftriaxone.

In conclusion, the incidence of erythromycin and clindamycin resistance has increased. Penicillin showed good susceptibility rates but rising MIC values are alarming. In the present study, there were 3 strains with raised MIC values, which is a very significant finding as penicillin is the drug of choice for *Streptococcus pyogenes* infections. So, it is significant to reconsider the patterns of penicillin susceptibility. Clindamycin is the drug of choice for penicillin resistant GAS infections but its resistance is also on rise observed in 40% strains in the current study. This highlights the need for judicious use of antibiotics to prevent therapeutic failures.
